1. Figure 4 PET imaging in experimental pancreatic cancer
Figure 4 | PET imaging in experimental pancreatic cancer. a | Correlative imaging of orthotopically transplanted BxPC3 pancreatic tumour cells expressing a luciferase reporter gene. Bioluminescent optical imaging demonstrated the presence of tumours (T) in the area of surgical transplantation. b | MRI validated the observed tumour presence from bioluminescent optical imaging. c | The co-registration of 18F-FDG PET and CT (left panel) and planar sections of 18F-FDG PET only (right panel) displayed minimal tumour detection of the tracer with a high uptake in highly metabolic tissues: for instance, the heart (H) d | Acquired 89Zr-5B1 PET image of the same mouse co-registered with CT exhibited exceptional tumour detection of the xenografts of BxPC3 tumour cells expressing a luciferase reporter gene. B, bladder. This research was adapted from the Journal of Nuclear Medicine111. Viola-Villegas, N. T. et al. Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology. J Nucl Med 2013; 54:1876–1882. © by the Society of Nuclear Medicine and Molecular Imaging, Inc.
This research was adapted from the Journal of Nuclear
Medicine111. Viola-Villegas, N. T. et al. Applying PET to broaden
the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.
J Nucl Med 2013; 54:1876–1882. © by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Dimastromatteo, J. et al. (2016) Imaging in pancreatic disease
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro